Skip to main content

UBS Group AG

Position in CNTX — Context Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in CNTX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$16,212
+$15,492 QoQ
Shares Held
6,188
+1162.9% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 59 holders
Holding Since
Jun 2022
11 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CNTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,969,172 across 554 Biotechnology names. CNTX ranks #436 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CNTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,212 6,188
2025-12-31 $720 490
2025-09-30 $7,153 7,382
2025-06-30 $242 370
2025-03-31 $264 432
2024-12-31 $734,084 699,129
2024-09-30 $3,365 1,717
2023-12-31 $10,723 9,490
2023-03-31 $3,241 5,767
2022-12-31 $1,796 2,755
2022-06-30 $7,689 3,627